PT - JOURNAL ARTICLE AU - Liu, Baike AU - Liu, Zheran AU - Jiang, Tianxiang AU - Gu, Xiangshuai AU - Yin, Xiaonan AU - Cai, Zhaolun AU - Zou, Xiaoqiao AU - Dai, Lei AU - Zhang, Bo TI - Appraising the causal association between gut microbiota and immune-related adverse events: perspectives from a bi-directional Mendelian randomization study AID - 10.1101/2023.07.24.23292742 DP - 2023 Jan 01 TA - medRxiv PG - 2023.07.24.23292742 4099 - http://medrxiv.org/content/early/2023/07/27/2023.07.24.23292742.short 4100 - http://medrxiv.org/content/early/2023/07/27/2023.07.24.23292742.full AB - Background Emerging evidence suggested that the gut microbiota associated with the development of immune-related adverse effects (irAEs) among cancer patients receiving immune checkpoint inhibitors (ICIs), but their roles remain largely unknown, and the causal associations are yet to be clarified.Methods Bi-directional two-sample Mendelian randomization (MR) approach was employed to examine the potential causal relationship between the gut microbiome and irAEs (high-grade irAEs and all-grade irAEs). Instrumental variables (IVs) for gut microbiota were retrieved from the MiBioGen consortium (18,340 participants). GWAS summary data for instrument-outcome associations were gathered from an ICIs-treated cohort with 1,751 cancer patients. Inverse variance weighted (IVW), MR PRESSO, maximum likelihood (ML), weighted median, weighted mode, and cML-MA-BIC were used in the MR analysis. Reverse MR analysis was performed on the identified bacteria that were causally associated with irAEs.Results Fourteen gut bacterial taxa identified by IVW and MR PRESSO were causally associated with irAEs, among which Lachnospiraceae was shown to increase the risk of both high-grade and all-grade irAEs. Akkermansia, Verrucomicrobiaceae, and Anaerostipes were found to exert protective roles in high-grade irAEs. Nevertheless, Ruminiclostridium6, Coprococcus3, Collinsella, and Eubacterium (fissicatena group) predispose to the development of high-grade irAEs. For all-grade irAEs, RuminococcaceaeUCG004, and DefluviitaleaceaeUCG011 were shown to have protective effects. While on the contrary, Porphyromonadaceae, Roseburia, Eubacterium (brachy group), and Peptococcus were associated with an elevated risk of all-grade irAEs.Conclusion Our MR analysis found that Lachnospiraceae and Akkermansia et al. were causally associated with the development of irAEs, which warrants further investigation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Nature Science Foundations of China (Grant number 82203108), China Postdoctoral Science Foundation (Grant number 2022M722275), and the Key R&D Program of Sichuan Province, China (Grant number 2023YFS0278).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted using public-available data. The GWAS summary statistics for gut microbiota are available at www.mibiogen.org, and GWAS summary statistics for irAEs are available at https://zenodo.org/record/6800429.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThis study was conducted using public-available data. The GWAS summary statistics for gut microbiota are available at www.mibiogen.org, and GWAS summary statistics for irAEs are available at https://zenodo.org/record/6800429.